fbpx
Veterans & Prostate Cancer

 

Check out this flyer and learn about the risks of prostate cancer for men, especially veterans.  To find out more, please join us on Thursday, August 30th for a free community event, “Veterans & Prostate Cancer:  What You Need to Know,” from 6 p.m. to 8 p.m. in the auditorium at St. Mary’s Regional Medical […]

 

Learn More

 

 

“Veterans & Prostate Cancer: What You Need to Know” Community Event

 

According to the U.S. Department of Veterans Affairs, 10,000 veterans are diagnosed with prostate cancer every year.  If you are a veteran, it is important to get your annual PSA screening, which can catch prostate cancer early, and if you have been diagnosed with prostate cancer, it is important to know all your treatment options.  Annual PSA […]

 

Learn More

 

 

Dr. Heuser’s CyberKnife Story

 

Watch general surgeon, Dr. Louis Heuser, talk about why he chose CyberKnife for the treatment of his prostate cancer. Dr. Heuser was very happy with the quick treatments and the fact that he was able to stay close to home and continue to work and see his patients. It’s Your Prostate, Your Cancer, Your Choice.

 

Learn More

 

 

Nonsurgical Prostate Cancer Treatment Available for Veterans at Reno Cyberknife

 

Physicians aim to inform Veterans about access to treatment options outside of VA Health Facilities through VA Choice Program In recognition of Veterans Day, November 11, 2017, Reno CyberKnife announced its participation in the VA Choice Program, which offers U.S. military veterans access to evidence-based prostate cancer treatment options outside of Veterans Health Administration facilities. Each […]

 

Learn More

 

 

Veterans and Prostate Cancer

 

 

Learn More

 

 

American Urological Association, American Society for Radiation Oncology, and the Society of Urologic Oncology Release Joint Prostate Cancer Guidelines

 

Last week, the American Urological Association (AUA), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO) released collaborative clinical guidelines for managing localized prostate cancer which offers a framework for shared decision-making between physicians and patients.  Through this collaboration, the committee provided guidance on active surveillance and on which treatments […]

 

Learn More

 

 

Ron Huber’s Story

 

Ron Huber was at a routine checkup when his primary doctor pointed out he was experiencing the telltale signs of prostate cancer. After a few lab tests, Huber’s doctors discovered he had elevated Prostate-Specific Antigens. He was diagnosed with prostate cancer in November 2016. Staying positive, Huber began to perform extensive research on all of […]

 

Learn More

 

 

Scientists Find New Gene Tool for Predicting Course of Prostate Cancer

 

A recent research paper in Oncotarget, a weekly peer-reviewed open access medical journal covering research on all aspects of oncology, reported that researchers from UR Medicine’s Wilmot Cancer Institute and Roswell Park Cancer Institute have discovered a possible new tool for predicting whether prostate cancer will reoccur following surgery based on the expression patterns of […]

 

Learn More

 

 

Lattie’s Story

 

 

Lattie’s Story

Watch Lattie Evans, Staff Sergeant, United States Army (Retired), talk about his experience receiving CyberKnife treatment for his prostate cancer at Reno CyberKnife. Lattie loved that there were no side effects after treatment and that he could hit the gym and work out like normal.

 

Learn More

 

 

Screening Strategy May Predict Lethal Prostate Cancer Later in Life

 

A recent study found that mid-life prostate-specific antigen (PSA) levels predict who will be more likely to develop lethal prostate cancer.  Investigators from Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health found that measuring PSA levels in younger men (between the ages of 40 and 59) could accurately predict future […]

 

Learn More